跳至主要内容
临床试验/CTRI/2023/08/056963
CTRI/2023/08/056963尚未招募3 期

Randomised controlled clinical trial to compare the efficacy of dhatryadi kwath and vasadi kwath in management of vatarakta.

Vd Ravindra Namdev Sagbhor1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年4月9日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
Reduction in the classical sign and symptoms of vatarakta.

研究概览

简要总结

The aim of study is to compare clinically the efficacy of Dhatryadi kwath with madhu and Vasadi kwath with Erandtail in management of Vatarakta (gout). To study in detail about vatarakta according to ayurvedic classics and observe any adverse effects. The trial will be conducted on 150 patients showing sign and symptoms of vatarakta in 02 groups, also serum uric acid level will be checked on the day of patient enrollment. Medicine will be given for 90 days, at the interval of 30 days patients will be assess the effect of therapy on objective parameters as well as subjective parameters. after 90 days of trial collected data of subjective and  objective parameters will be statistically assess and conclusion will be drawn.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran.
  • Patient of any sex, religion and socio-economic status.
  • 2.newly diagnosed patient.
  • 3.Patient with serum uric acid >7mg/dl in male and 6mg/dl in female.

排除标准

  • 1.Pathophysiology or genetic syndrome associated with vatarakta.
  • 2.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded.
  • 3 malignancy, poorly controlled DM,HTN.
  • 4.symptomatic patient with clinical evidence of heart failure.
  • 5.complicated patient having target organ damage.
  • 6.alcoholic and drug abusers, pregnant and lactating women.

结局指标

主要结局

Reduction in the classical sign and symptoms of vatarakta.

时间窗: 30th, 60th, 90th day

次要结局

  • 1.To assess efficacy of Dhatryadi kwath & Vasadi kwath in management of Vatarakta.(2.To assess any adverse effects of Dhatryadi kwath & Vasadi kwath in management of Vatarakta.)

研究者

发起方
Vd Ravindra Namdev Sagbhor
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

To study the efficacy of Dhatryadi kwath and Vasadi... | 临床试验